GENFIT (EPA:GNFT) | WebDisclosure

Basculer en Français

10681	Companies
228031	Keywords
156526	Articles
120883	Press releases

Home
Companies
GENFIT

PRESS RELEASE

published on 02/10/2025 at 07:30, 1 year 4 months ago

GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs Holders
GENFIT announces final terms for dual proposal to the 2025 OCEANEs holders, offering to repurchase bonds at EUR 32.00 or pay a consent fee of EUR 0.60 per bond. Proposals subject to bondholders' approval and closing of royalty financing

Repurchase Royalty Financing GENFIT Consent Fee 2025 OCEANEs
PRESS RELEASE

published on 02/10/2025 at 07:30, 1 year 4 months ago

GENFIT annonce les termes définitifs de sa double proposition aux porteurs d’OCEANEs 2025
GENFIT annonce les termes de sa double proposition aux porteurs d'OCEANEs 2025, incluant le rachat des obligations ou un paiement financier, liés au royalty financing avec HCRx. Modalités d'approbation et mise en œuvre

Rachat Royalty Financing GENFIT OCEANEs 2025 Contrepartie Financière
BRIEF

published on 02/06/2025 at 22:15, 1 year 4 months ago

GENFIT dévoile ses futurs essais cliniques et attentes pour 2025

Biopharmaceutique Essais Cliniques 2025 GENFIT ACLF
BRIEF

published on 02/06/2025 at 22:15, 1 year 4 months ago

GENFIT unveils its future clinical trials and expectations for 2025

Clinical Trials Biopharmaceutical 2025 GENFIT ACLF
PRESS RELEASE

published on 02/06/2025 at 22:10, 1 year 4 months ago

GENFIT présente le design de ses prochains essais cliniques et rappelle les grandes étapes de développement et données cliniques attendues en 2025
GENFIT présente le design de ses prochains essais cliniques pour son portefeuille ACLF et rappelle les données cliniques attendues en 2025. Le Directeur Général annonce quatre séries de données cliniques attendues d'ici fin 2025

Développement Essais Cliniques GENFIT ACLF Données Cliniques
PRESS RELEASE

published on 02/06/2025 at 22:10, 1 year 4 months ago

GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025
GENFIT outlines anticipated new clinical trial initiations, development milestones, and data readouts in 2025, focusing on Acute on-Chronic Liver Failure (ACLF) pipeline

Clinical Trials Biopharmaceutical 2025 GENFIT ACLF Pipeline
BRIEF

published on 01/30/2025 at 08:45, 1 year 5 months ago

GENFIT Announces €185 Million Royalty Financing Agreement

Biopharmaceutical Royalty Financing GENFIT Debt Resolution ACLF Development
BRIEF

published on 01/30/2025 at 08:45, 1 year 5 months ago

GENFIT annonce un accord de financement de 185 millions d'euros sous forme de redevances

Biopharmaceutique GENFIT Résolution De La Dette Financement Par Redevances Développement De L'ACLF
PRESS RELEASE

published on 01/30/2025 at 08:40, 1 year 5 months ago

GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan
GENFIT announces non-dilutive royalty financing agreement with HealthCare Royalty, resolving debt overhang. Transaction to strengthen ACLF pipeline and extend cash runway into 2027

HealthCare Royalty Royalty Financing GENFIT Debt Overhang ACLF Pipeline
BRIEF

published on 01/13/2025 at 22:15, 1 year 5 months ago

Bilan semestriel du contrat de liquidité de GENFIT avec le CIC

Bilan Semestriel Liquidité Crédit Industriel Et Commercial Titres GENFIT

Accesswire

Published on 07/06/2026 at 02:25, 4 hours 28 minutes ago

Tunkillia Infill Drilling Delivers More High-Grade Assays
Published on 07/03/2026 at 23:00, 2 days 7 hours ago

Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 23:00, 2 days 7 hours ago

Medicure Announces CFO Change
Published on 07/03/2026 at 21:28, 2 days 9 hours ago

Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 2 days 11 hours ago

Polaris Renewable Energy Announces Q2 2026 Investor Call Details

View all ACCESSWIRE

EQS Group

Published on 07/06/2026 at 02:33, 4 hours 20 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Portfolio valuations update
Published on 07/06/2026 at 02:05, 4 hours 48 minutes ago

FGR to launch PureGRAPH® CEM into China
Published on 07/05/2026 at 13:45, 17 hours 8 minutes ago

XPPen renforce son engagement en faveur de l’animation grâce à son partenariat avec la Résidence du Festival d’Annecy 2026 et sa présence au MIFA
Published on 07/05/2026 at 13:45, 17 hours 8 minutes ago

XPPen Strengthens Its Commitment to Animation with 2026 Annecy Festival Residency Partnership and MIFA Showcase
Published on 07/04/2026 at 17:35, 1 day 13 hours ago

Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247

Les Echos

Published on 07/03/2026 at 21:49, 2 days 9 hours ago

Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 2 days 9 hours ago

Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 2 days 12 hours ago

Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:42, 2 days 12 hours ago

Capital et droits de vote au 30 juin 2026
Published on 07/03/2026 at 18:36, 2 days 12 hours ago

Disclosure of transactions in own shares from July 1 to July 3, 2026

View all LES ECHOS COMFI WIRE